UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Regulated cell death pathways in doxorubicin-induced cardiotoxicity

Cell death & disease, 2021-04, Vol.12 (4), p.339-15, Article 339

2021

Volltextzugriff (PDF)

Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia

Arteriosclerosis, thrombosis, and vascular biology, 2021-10, Vol.41 (10), p.2632-2640

2021

Volltextzugriff (PDF)

Chromosome 1q21.2 and additional loci influence risk of spontaneous coronary artery dissection and myocardial infarction

Nature communications, 2020-09, Vol.11 (1), p.4432-4432, Article 4432

2020

Volltextzugriff (PDF)

The effects of cholesterol accumulation on Achilles tendon biomechanics: A cross-sectional study

PloS one, 2021-09, Vol.16 (9), p.e0257269-e0257269

2021

Volltextzugriff (PDF)

Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia

Journal of the American College of Cardiology, 2020-06, Vol.75 (21), p.2682-2693

2020

Volltextzugriff (PDF)

Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes

Scientific reports, 2016-05, Vol.6 (1), p.25333, Article 25333

2016

Volltextzugriff (PDF)

Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence

Cardiovascular research, 2018-07, Vol.114 (8), p.1073-1081

2018

Volltextzugriff (PDF)

Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes

Scientific reports, 2020-06, Vol.10 (1), p.10363, Article 10363

2020

Volltextzugriff (PDF)

Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis

Circulation (New York, N.Y.), 2021-03, Vol.143 (9), p.921-934

2021

Volltextzugriff (PDF)

Premature Atherosclerotic Cardiovascular Disease: Trends in Incidence, Risk Factors, and Sex-Related Differences, 2000 to 2016

Journal of the American Heart Association, 2019-07, Vol.8 (14), p.e012178

2019

Volltextzugriff (PDF)

Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018

Canadian journal of cardiology, 2018-12, Vol.34 (12), p.1553-1563

2018

Volltextzugriff (PDF)

Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients

PloS one, 2017-10, Vol.12 (10), p.e0186200-e0186200

2017

Volltextzugriff (PDF)

Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?

Current opinion in lipidology, 2024-08, Vol.35 (4), p.219-221

Brunham, Liam R

2024

Volltextzugriff (PDF)

Simplified Canadian Definition for Familial Hypercholesterolemia

Canadian journal of cardiology, 2018-09, Vol.34 (9), p.1210-1214

2018

Volltextzugriff (PDF)

Sex Differences in the Presentation, Treatment, and Outcome of Patients With Familial Hypercholesterolemia

Journal of the American Heart Association, 2021-06, Vol.10 (11), p.e019286-e019286

2021

Volltextzugriff (PDF)

Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I

The Journal of clinical investigation, 2005-05, Vol.115 (5), p.1333-1342

2005

Volltextzugriff (PDF)

Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia

Circulation. Genomic and precision medicine, 2020-10, Vol.13 (5), p.515-523

2020

Volltextzugriff (PDF)

Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial

BMC medicine, 2018-07, Vol.16 (1), p.104-104, Article 104

2018

Volltextzugriff (PDF)

Familial hypercholesterolemia in Canada: Initial results from the FH Canada national registry

Atherosclerosis, 2018-10, Vol.277, p.419-424

2018

Volltextzugriff (PDF)

Establishing multiple omics baselines for three Southeast Asian populations in the Singapore Integrative Omics Study

Nature communications, 2017-09, Vol.8 (1), p.653-11, Article 653

2017

Volltextzugriff (PDF)

Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease

Arteriosclerosis, thrombosis, and vascular biology, 2020-01, Vol.40 (1), p.267-278

2020

Volltextzugriff (PDF)

Islet Cholesterol Accumulation Due to Loss of ABCA1 Leads to Impaired Exocytosis of Insulin Granules

Diabetes (New York, N.Y.), 2011-12, Vol.60 (12), p.3186-3196

2011

Volltextzugriff (PDF)

HDL and pancreatic β cells: a SMO-king gun?

Journal of lipid research, 2020-04, Vol.61 (4), p.468-469

Brunham, Liam R.

2020

Volltextzugriff (PDF)

Contemporary Trends in the Management and Outcomes of Patients with Familial Hypercholesterolemia in Canada: A Prospective Observational Study

Canadian journal of cardiology, 2017-03, Vol.33 (3), p.385-392

2017

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(129)

Publikationsform

Sprache

Englisch
(162)

Erscheinungsjahr

n.n

Thema

Science & Technology
(118)
Life Sciences & Biomedicine
(108)
Humans
(87)
Cardiovascular System & Cardiology
(53)
Cardiac & Cardiovascular Systems
(41)
Female
(34)
Male
(32)
Middle Aged
(24)
Adult
(23)
Atherosclerosis
(23)
Cholesterol
(23)
Risk Factors
(23)
Lipids
(20)
Peripheral Vascular Disease
(20)
Animals
(18)
Atp Binding Cassette Transporter 1
(18)
Pharmacology & Pharmacy
(16)
Atp-Binding Cassette Transporters - Genetics
(15)
Cardiovascular Disease
(15)
Mutation
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Regulated cell death pathways in doxorubicin-induced cardiotoxicity

Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia

Chromosome 1q21.2 and additional loci influence risk of spontaneous coronary artery dissection and myocardial infarction

The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification

The effects of cholesterol accumulation on Achilles tendon biomechanics: A cross-sectional study

Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia

Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes

Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence

Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes

Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis

Premature Atherosclerotic Cardiovascular Disease: Trends in Incidence, Risk Factors, and Sex-Related Differences, 2000 to 2016

Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018

Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients

Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?

Simplified Canadian Definition for Familial Hypercholesterolemia

Sex Differences in the Presentation, Treatment, and Outcome of Patients With Familial Hypercholesterolemia

Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I

Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia

Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial

Familial hypercholesterolemia in Canada: Initial results from the FH Canada national registry

Establishing multiple omics baselines for three Southeast Asian populations in the Singapore Integrative Omics Study

Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease

Islet Cholesterol Accumulation Due to Loss of ABCA1 Leads to Impaired Exocytosis of Insulin Granules

HDL and pancreatic β cells: a SMO-king gun?

Contemporary Trends in the Management and Outcomes of Patients with Familial Hypercholesterolemia in Canada: A Prospective Observational Study

Suchergebnisse filtern